Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Piretanide is a loop diuretic compound by using a then-new method for introducing cyclic amine residues in an aromatic nucleus in the presence of other aromatically bonded functional groups. Studies of piretanide in rats and dogs in comparison with other high-ceiling diuretics such as furosemide and bumetanide found a more suitable dose/response rate…
Standards & Overview
Explore the main themes, entities and connections around Piretanide. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
names studies excretion brand arelix eurelix tauliz furosemide bumetanide loop diuretic compound using then-new method introducing cyclic amine residues aromatic
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Piretanide | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Piretanide | AHFS/Drugs.com | International Drug Names | 1.00 | infobox |
| Piretanide | ATC code | C03CA03 (WHO) | 1.00 | infobox |
| Piretanide | Bioavailability | ~90% | 1.00 | infobox |
| Piretanide | CAS Number | 55837-27-9 Y | 1.00 | infobox |
| Piretanide | ChemSpider | 4683 N | 1.00 | infobox |
| Piretanide | CompTox Dashboard (EPA) | DTXSID2023488 | 1.00 | infobox |
| Piretanide | DrugBank | DB02925 N | 1.00 | infobox |
| Piretanide | ECHA InfoCard | 100.054.394 | 1.00 | infobox |
| Piretanide | Excretion | Urine (60%), feces (40%) | 1.00 | infobox |
| Piretanide | Formula | C17H18N2O5S | 1.00 | infobox |
| Piretanide | IUPHAR/BPS | 4742 | 1.00 | infobox |
| Piretanide | KEGG | D01634 Y | 1.00 | infobox |
| Piretanide | Legal status | EU: Rx-only | 1.00 | infobox |
| Piretanide | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Piretanide | Metabolism | not identified | 1.00 | infobox |
| Piretanide | Molar mass | 362.40 g·mol−1 | 1.00 | infobox |
| Piretanide | Protein binding | 96% | 1.00 | infobox |
| Piretanide | PubChem CID | 4849 | 1.00 | infobox |
| Piretanide | Routes of administration | By mouth | 1.00 | infobox |
| Piretanide | Trade names | Arelix, Eurelix, Tauliz, others | 1.00 | infobox |
| Piretanide | UNII | DQ6KK6GV93 | 1.00 | infobox |
| Piretanide | is a | loop diuretic compound by using a then-new method for introducing cyclic amine residues in an aromatic nucleus in the presence of other aromatically bonded functional groups | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.